Cessatech Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cessatech
Access all reports
Cessatech A/S is a biopharmaceutical company dedicated to identifying, developing and commercializing drugs for children with the potential to treat cancer and fibrotic disorders. The company's focus of research and development is based on the proteins in regulatory T-cells (Tregs) that suppress an immune system response to secondary disease processes, such as cancer and fibrosis.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CESSA
Country
🇩🇰 Denmark